|
DNTTIP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.873200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.935800E-01 |
| Normal-vs-Stage2 |
9.327000E-01 |
| Normal-vs-Stage3 |
3.260200E-02 |
| Normal-vs-Stage4 |
4.209800E-02 |
| Stage1-vs-Stage2 |
7.020400E-01 |
| Stage1-vs-Stage3 |
1.717550E-03 |
| Stage1-vs-Stage4 |
1.716880E-03 |
| Stage2-vs-Stage3 |
1.782170E-01 |
| Stage2-vs-Stage4 |
1.881380E-01 |
| Stage3-vs-Stage4 |
9.764600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.053600E-01 |
| Normal-vs-AfricanAmerican |
2.171000E-01 |
| Normal-vs-Asian |
4.316200E-01 |
| Caucasian-vs-AfricanAmerican |
2.515600E-01 |
| Caucasian-vs-Asian |
6.334200E-01 |
| AfricanAmerican-vs-Asian |
9.858800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.725000E-01 |
| Normal-vs-Female |
3.651400E-01 |
| Male-vs-Female |
8.995200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.512800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.521600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.810400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.458200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.559600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.989200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.854800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.138200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.503000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.870000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.151170E-01 |
| Normal-vs-Grade 2 |
4.378300E-02 |
| Normal-vs-Grade 3 |
1.725650E-02 |
| Normal-vs-Grade 4 |
6.138900E-03 |
| Grade 1-vs-Grade 2 |
3.576600E-01 |
| Grade 1-vs-Grade 3 |
1.084250E-03 |
| Grade 1-vs-Grade 4 |
1.217380E-03 |
| Grade 2-vs-Grade 3 |
1.27209999978284E-07 |
| Grade 2-vs-Grade 4 |
1.81040000002408E-06 |
| Grade 3-vs-Grade 4 |
3.782000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.662300E-03 |
| Normal-vs-ccB subtype |
1.462120E-03 |
| ccA subtype-vs-ccB subtype |
1.54090074033775E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.618800E-01 |
| Normal-vs-N1 |
6.798400E-02 |
| N0-vs-N1 |
2.077800E-01 |
|
|
